PRT062607 (Hydrochloride)

PRT062607 (Hydrochloride) Basic information
Product Name:PRT062607 (Hydrochloride)
Synonyms:PRT062607 (Hydrochloride);PRT062607 (P505-15, BIIB057) HCl;P505-15 hydrochloride;CS-995;BIIB057 HCl;4-((4-(2H-1,2,3-Triazol-2-yl)phenyl)amino)-2-(((1R,2S)-2-aminocyclohexyl)amino)pyrimidine-5-carboxamide hydrochloride;P505-15; PRT2607; PRT-2607; PRT 2607; PRT-062607; PRT 062607; P505-15; BIIB057;2-[[(1R,2S)-2-AMinocyclohexyl]aMino]-4-[[3-(2H-1,2,3-triazol-2-yl)phenyl]aMino]-5-pyriMidinecarboxaMide Hydrochloride
CAS:1370261-97-4
MF:C19H24ClN9O
MW:429.90656
EINECS:
Product Categories:Inhibitors;Pharmaceuticals, Intermediates & Fine Chemicals
Mol File:1370261-97-4.mol
PRT062607 (Hydrochloride) Structure
PRT062607 (Hydrochloride) Chemical Properties
storage temp. Store at -20°C
solubility ≥21.5 mg/mL in DMSO; insoluble in EtOH; ≥83.2 mg/mL in H2O with gentle warming
form solid
Safety Information
MSDS Information
PRT062607 (Hydrochloride) Usage And Synthesis
UsesPRT062607 (Hydrochloride)acts as a novel spleen tyrosine kinase (syk) inhibitors used in the treatment of leukemia.
targetSyk
PRT062607 (Hydrochloride) Preparation Products And Raw materials
Ibrutinib Ponatinib PD 0332991 HCl Trametinib R406 Entospletinib (GS-9973)

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.